Table 2

Revascularisation rates at 30 days

ProcedureUFH (n = 1564)Enoxaparin (n = 1607)Relative risk reduction (%)p Value
CABG214 (13.7)198 (12.3)10.00.254
PTCA293 (18.7)236 (14.7)21.60.002
Total504 (32.2)434 (27.0)16.00.001
  • Values are n (%).

  • CABG, coronary artery bypass grafting; PTCA, percutaneous transluminal coronary angioplasty.

  • Reproduced from Cohen et al 7with permission of the Massachusetts Medical Society.